Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J’s Simponi Fails to Receive U.S. FDA Clearance for Wider Use
Bloomberg
Saturday, September 10, 2011 - 10:36am
tags:
JNJ, Simponi, psoriatic arthritis, arthritis
Has Pfizer Fizzled?
Seeking Alpha
Saturday, September 10, 2011 - 10:28am
tags:
Pfizer
GSK Halts Part of Breast Cancer Trial; Drug Can't Top Herceptin
Motley Fool
Saturday, September 10, 2011 - 10:28am
tags:
GSK, breast cancer, Tykerb
Positive Data on Teva Candidate
Yahoo/Zacks
Saturday, September 10, 2011 - 10:26am
tags:
Alcobra, Teva Pharmaceuticals, ADHD, MG01CI
The Rivaroxaban (Xarelto) FDA Panel and Large Pragmatic Trials
Forbes
Saturday, September 10, 2011 - 10:25am
tags:
Xarelto, JNJ, anti-clotting, atrial fibrillation, FDA
Dendreon A Buy Amid Restructuring
Forbes
Saturday, September 10, 2011 - 10:22am
tags:
Dendreon
4 Healthcare Stocks With Smart Money And Insider Buying
Seeking Alpha
Saturday, September 10, 2011 - 10:20am
tags:
Sequenom, Akorn, Genomic Health, Theravance
Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium
Yahoo/PR NewsWire
Saturday, September 10, 2011 - 9:59am
tags:
NKTR-102, Nektar, breast cancer
Ardea Agrees with FDA on Gout Candidate
Yahoo/Zacks
Saturday, September 10, 2011 - 9:57am
tags:
RDEA594, lesinurad, gout, Ardea
Regeneron Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Saturday, September 10, 2011 - 9:55am
tags:
Regeneron, Eylea, age-related macular degeneration
Dendreon: Righting The Ship
Seeking Alpha
Saturday, September 10, 2011 - 9:54am
tags:
Dendreon
Neuvenge: Dendreon's Treatment For Bladder Cancer
Seeking Alpha
Saturday, September 10, 2011 - 9:53am
tags:
Neuvenge, Dendreon, bladder cancer
GSK stops Tykerb-only arm in cancer trial
Fierce Pharma
Friday, September 9, 2011 - 12:02pm
tags:
GSK, Tykerb, Roche, Herceptin, breast cancer
[video] The Next Big Thing in Biotech: Immunogen
TheStreet.com
Friday, September 9, 2011 - 11:59am
tags:
Immunogen
Are Shorts Watching This Number at Novo Nordisk?
Motley Fool
Friday, September 9, 2011 - 11:57am
tags:
Novo Nordisk
Sanofi Projects Growth Despite Challenges
Seeking Alpha
Friday, September 9, 2011 - 11:47am
tags:
Sanofi, Plavix, Avapro
Anti-Clotting Stumble For J&J/Bayer Likely to Help Pfizer/Bristol-Meyers
Seeking Alpha
Friday, September 9, 2011 - 11:36am
tags:
JNJ, Bayer, Pfizer, Bristol-Myers Squibb, Xarelto
Patent Reform, A Drugmaker & A Special Favor
Pharmalot
Friday, September 9, 2011 - 11:30am
tags:
patents, Medicines Company
Citi analyst expects FDA approval of J&J anticlotting drug after committee recommendatio
Yahoo/AP
Friday, September 9, 2011 - 11:23am
tags:
FDA, JNJ, Xarelto, bloodthinners, Bayer
Novartis AG: Dividend Stock Analysis
Seeking Alpha
Friday, September 9, 2011 - 11:21am
tags:
dividends, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.